[1] MURRAY C J L, GBD 2021 Collaborators. Findings from the Global Burden of Disease Study 2021[J]. Lancet, 403(10440):2259-2262. [2] WANG L, XU X, ZHANG M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance[J]. JAMA Intern Med, 2023, 183(4): 298-310. [3] 中华医学会老年医学分会肾病学组, 国家老年疾病临床医学研究中心. 老年慢性肾脏病诊治的中国专家共识(2018)[J]. 中华老年病研究电子杂志, 2018, 5(3): 1-8. [4] TOTH-MANIKOWSKI S M, YANG W, APPEL L, et al. Sex differences in cardiovascular outcomes in CKD: findings from the CRIC study[J]. Am J Kidney Dis, 2021, 78(2): 200-209.e1. [5] ZHANG L, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822. [6] DELANAYE P, GLASSOCK R J, POTTEL H, et al. An age-calibrated definition of chronic kidney disease: rationale and benefits[J]. Clin Biochem Rev, 2016, 37(1): 17-26. [7] RAMAN M, GREEN D, MIDDLETON R J, et al. Comparing the impact of older age on outcome in chronic kidney disease of different etiologies: a prospective cohort study[J]. J Nephrol, 2018, 31(6): 931-939. [8] DELANAYE P, JAGER K J, BÖKENKAMP A, et al. CKD: a call for an age-adapted definition[J]. J Am Soc Nephrol, 2019, 30(10): 1785-1805. [9] 上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南(2022年版)[J]. 中华肾脏病杂志, 2022, 38(5): 453-464. [10] WANG S, CHEN R, LIU Q, et al. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study[J]. Nephrology, 2015, 20(7): 474-484. [11] 覃丽虹, 陈静, 向涯碟, 等. 1990—2021年我国慢性肾脏病疾病负担及其危险因素分析[J]. 医学新知, 2024,34(9): 957-969. [12] BEETHAM K S, KRISHNASAMY R, STANTON T, et al. Effect of a 3-year lifestyle intervention in patients with chronic kidney disease: a randomized clinical trial[J]. J Am Soc Nephrol, 2022, 33(2): 431-441. [13] 周锦辉, 魏源, 吕跃斌, 等. 中国8个长寿地区65岁及以上老年人慢性肾脏病的6年发生风险预测[J]. 中华流行病学杂志, 2020, 41(1): 42-47. [14] FRANCIS A, HARHAY M N, ONG A C M, et al. Chronic kidney disease and the global public health agenda: an international consensus[J]. Nat Rev Nephrol, 2024, 20(7): 473-485. [15] TANGRI N, GRAMS M E, LEVEY A S, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis[J]. JAMA, 2016, 315(2): 164-174. [16] NELSON R G, GRAMS M E, BALLEW S H, et al. Development of risk prediction equations for incident chronic kidney disease[J]. JAMA, 2019, 322(21): 2104-2114. [17] BANSAL N, KATZ R, DE BOER I H, et al. Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD[J]. Clin J Am Soc Nephrol, 2015, 10(3): 363-371. [18] ALI I, KALRA P. Risk prediction in chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2019, 28(6): 513-518. [19] NEUMANN D, MAU W, WIENKE A, et al. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course[J]. Kidney Int, 2018, 93(2): 430-438. [20] TIAN X, GUO X, XIA X, et al. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis[J]. Medicine, 2019, 98(6): e14390. [21] ALI H, SOLIMAN K, MOHAMED M M, et al. The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: a systematic review and meta-analysis[J]. Int Urol Nephrol, 2021, 53(1): 155-163. |